Circadian rhythm abnormalities have been described in various psychiat
ric disorders, but they have not received much attention in studies of
schizophrenia and schizophreniform psychosis. The present study used
the cosine model to determine the circadian patterns of amino acids, d
opamine, and prolactin concentrations, which were analyzed over a 24-h
our period in serum of healthy subjects, drug-free schizophrenic patie
nts, and neuroleptic-treated schizophrenic patients. The mesor (the da
ily mean) of phenylalanine was lower in drug-free schizophrenic women
than in healthy women. The mesors of the ratio of phenylalanine or tyr
osine to competing amino acids were similar in healthy subjects and pa
tients. The ratio of phenylalanine/competing amino acids showed a phas
e advance (i.e., earlier onset of the time of highest concentration) i
n drug-free patients compared with healthy subjects. Schizophrenic pat
ients displayed a higher dopamine mesor than healthy subjects. Female
drug-free schizophrenic patients had lower prolactin mesors and lower
amplitudes (i.e., half of the total predictable change in rhythm) than
healthy women. Compared with healthy subjects, schizophrenic patients
showed a phase advance of circadian prolactin concentrations. Neurole
ptics raised the prolactin mesor and amplitudes but did not elicit any
phase change in amino acids, dopamine, or prolactin. These data confi
rm the indirect pharmacologic evidence of increased dopaminergic activ
ity in schizophrenic patients that relates to dopamine's precursors an
d to the neuroendocrine regulation of prolactin.